Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Trovagene Names Elander as CSO; Curetis Hires Hilbert to Head Biz Development

Premium

Trovagene said this week that it has appointed Mark Elander as chief scientific officer. Erlander will direct the clinical development program for the company's portfolio of transrenal and urine-based molecular diagnostic assays. He will also oversee the ongoing clinical program for Trovagene's human papilloma virus carrier screening assay.

Elander previously served as CSO of BioTheranostics, a BioMérieux company. Prior to this, he was a research fellow at the RW Johnson Pharmaceutical Research Institute, part of Johnson & Johnson. He has also been a postdoctoral fellow in the Department of Molecular Biology at Scripps Research Institute. He holds a BS in biochemistry from the University of California, Davis; an MS in biochemistry from Iowa State University, and a PhD in neuroscience from the University of California, Los Angeles.


Curetis this week said that it has appointed Helmut Hilbert as head of business development.

Hilbert was previously employed by Qiagen, where he served in a number of scientific and business development positions, most recently associate director of corporate business development. He holds a PhD in molecular biology from the Open University/University of Heidelberg.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.